{"transactions":[{"id":1000435,"issuer":{"id":8263,"kind":"organization","name":"Apimeds Pharmaceuticals US, Inc."},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-13T23:28:02.000Z","date":"2025-11-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's employment continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the Company's incentive plan (the \"Plan\") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full vest upon the occurrence of a Change in Control, as defined in the Plan."}],"balance_after":10000,"derivative":{"exercise_price":2.67,"expiration_date":"2035-11-11","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001679971-25-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894525/000167997125000008/primary_doc.xml","form_type":"4"}},{"id":1013879,"issuer":{"id":8263,"kind":"organization","name":"Apimeds Pharmaceuticals US, Inc."},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-24T20:35:10.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's service to the issuer continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the issuer's incentive plan (the \"Plan\") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full upon the occurrence of a Change in Control, as defined in the Plan."}],"balance_after":3000,"derivative":{"exercise_price":1.92,"expiration_date":"2035-10-15","underlying":"Common Stock, par value $0.01 per share","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001679971-25-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894525/000167997125000007/primary_doc.xml","form_type":"4"}},{"id":1140632,"issuer":{"id":8263,"kind":"organization","name":"Apimeds Pharmaceuticals US, Inc."},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-20T21:18:55.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":5780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full and become exercisable on 05/16/2026."}],"balance_after":5780,"derivative":{"exercise_price":1.73,"expiration_date":"2035-05-16","underlying":"Common Stock, par value $0.01 per share","underlying_shares":5780},"source":{"system":"sec-edgar","filing":"0001474506-25-000103","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894525/000147450625000103/primary_doc.xml","form_type":"4"}},{"id":1622667,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-23T22:32:38.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is subject to vesting requirements based upon achievement of specified performance-based criteria (the \"Stock Price Hurdle\") which requires that the Issuer achieve a stock price equal to or greater than 200% of the option exercise price during the period beginning on the grant date and ending on February 6, 2031 (the \"Performance Period\"). If the Stock Price Hurdle is achieved within the Performance Period, then one-fourth of the shares subject to the option vest on the date that achievement of the Stock Price Hurdle is certified and the remaining shares vest annually thereafter in three equal installments."}],"balance_after":140000,"derivative":{"exercise_price":1.77,"expiration_date":"2034-02-06","underlying":"Class A Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001415889-24-005096","document":"form4-02232024_100220.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000141588924005096/form4-02232024_100220.xml","form_type":"4"}},{"id":1622666,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-23T22:32:38.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":79729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth of the shares subject to the option vest on February 6, 2025 and 1/48th of the shares vest monthly thereafter."}],"balance_after":79729,"derivative":{"exercise_price":1.77,"expiration_date":"2034-02-06","underlying":"Class A Common Stock","underlying_shares":79729},"source":{"system":"sec-edgar","filing":"0001415889-24-005096","document":"form4-02232024_100220.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000141588924005096/form4-02232024_100220.xml","form_type":"4"}},{"id":1622665,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-02-23T22:32:38.000Z","date":"2024-02-22","kind":"sale","planned":false,"acquired":false,"shares":12684,"price":1.5787,"value":20024.2308,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of RSUs."}],"balance_after":273142,"source":{"system":"sec-edgar","filing":"0001415889-24-005096","document":"form4-02232024_100220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000141588924005096/form4-02232024_100220.xml","form_type":"4"}},{"id":1622664,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-02-23T22:32:38.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":123153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on February 15, 2025."}],"balance_after":285826,"source":{"system":"sec-edgar","filing":"0001415889-24-005096","document":"form4-02232024_100220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000141588924005096/form4-02232024_100220.xml","form_type":"4"}},{"id":1720130,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-06T21:43:19.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":8182,"price":1.6951,"value":13869.3082,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,168 shares and 3,100 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 15, 2023 and November 15, 2023, respectively."}],"balance_after":162673,"source":{"system":"sec-edgar","filing":"0001209191-23-057620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919123057620/doc4.xml","form_type":"4"}},{"id":2000001,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2023-02-23T00:09:55.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":5951,"price":4.1343,"value":24603.2193,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,168 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on November 15, 2022."}],"balance_after":166587,"source":{"system":"sec-edgar","filing":"0001209191-23-011919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919123011919/doc4.xml","form_type":"4"}},{"id":2007776,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-18T00:53:59.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is subject to vesting requirements based upon achievement of specified performance-based criteria (the \"Stock Price Hurdle\") which requires that the Issuer achieve a stock price equal to or greater than 150% of the option exercise price during the period beginning on the grant date and ending on February 15, 2030 (the \"Performance Period\").  If the Stock Price Hurdle is achieved within the Performance Period, then one fourth of the shares subject to the option vest on the date that achievement of the Stock Price Hurdle is certified and the remaining shares vest annually thereafter in three equal installments."}],"balance_after":140000,"derivative":{"exercise_price":4.59,"expiration_date":"2033-02-15","underlying":"Class A Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001209191-23-010927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919123010927/doc4.xml","form_type":"4"}},{"id":2007775,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2023-02-18T00:53:59.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on February 15, 2024."}],"balance_after":171370,"source":{"system":"sec-edgar","filing":"0001209191-23-010927","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919123010927/doc4.xml","form_type":"4"}},{"id":2236081,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2022-06-11T00:17:53.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":8185,"price":8.9094,"value":72923.439,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.80 to $9.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 827 shares of Class A Common Stock acquired under the Issuer's employee stock purchase plan on November 15, 2021."}],"balance_after":101370,"source":{"system":"sec-edgar","filing":"0001209191-22-036155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919122036155/doc4.xml","form_type":"4"}},{"id":2404401,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-11T00:13:58.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":124000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth of the shares subject to the option vest on February 8, 2023 and 1/48th of the shares vest monthly thereafter."}],"balance_after":124000,"derivative":{"exercise_price":16.61,"expiration_date":"2032-02-08","underlying":"Class A Common Stock","underlying_shares":124000},"source":{"system":"sec-edgar","filing":"0001209191-22-008619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919122008619/doc4.xml","form_type":"4"}},{"id":2404400,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2022-02-11T00:13:58.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on February 15, 2023."}],"balance_after":108728,"source":{"system":"sec-edgar","filing":"0001209191-22-008619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919122008619/doc4.xml","form_type":"4"}},{"id":2953571,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2020-12-09T00:27:27.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":46728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, pursuant to which 50% vest on June 8, 2022 and the remaining shares vest on December 8, 2023."}],"balance_after":46728,"source":{"system":"sec-edgar","filing":"0001628280-20-017232","document":"wf-form4_160747363396161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000162828020017232/wf-form4_160747363396161.xml","form_type":"4"}},{"id":3318310,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-07T01:08:14.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 25% on January 2, 2021. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":140000,"derivative":{"exercise_price":2.3,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001453687-20-000013","document":"wf-form4_157835927771425.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368720000013/wf-form4_157835927771425.xml","form_type":"4"}},{"id":3433132,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-08-20T20:32:11.000Z","date":"2019-08-20","kind":"grant","acquired":true,"shares":82872,"price":1.81,"value":149998.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Total shares reported includes 50,000 shares underlying unvested restricted stock units."}],"balance_after":182872,"source":{"system":"sec-edgar","filing":"0001453687-19-000123","document":"wf-form4_156633311554335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368719000123/wf-form4_156633311554335.xml","form_type":"4"}},{"id":3576457,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-27T20:17:50.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 25% on March 20, 2020. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":400000,"derivative":{"exercise_price":2.29,"expiration_date":"2029-03-24","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001679971-19-000005","document":"wf-form4_155371785653312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000167997119000005/wf-form4_155371785653312.xml","form_type":"4"}},{"id":3576456,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-03-27T20:17:50.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying Restricted Stock Unit awards, which vest, and the underlying shares become issuable, upon achievement of specified performance goals."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001679971-19-000005","document":"wf-form4_155371785653312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000167997119000005/wf-form4_155371785653312.xml","form_type":"4"}},{"id":4443818,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. V. P. - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2017-02-16T14:14:32.000Z","date":"2017-02-16","kind":"disposition_to_issuer","acquired":false,"shares":6085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the Offer automatically and without any required action on the part of its holder shall be converted into the right to receive an amount in cash equal to $24.00 for each Share underlying the RSUs (the aggregate amount, the \"RSU Payment\").  Subject to the terms of the award agreement, the RSU Payment will generally be payable (without any crediting of interest for the period from the consummation of the Offer through the date of payment) in three annual installments with each such installment paid on the date that the RSUs corresponding to such installment would have otherwise vested in accordance with the terms of the award, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the Offer automatically and without any required action on the part of its holder shall be converted into the right to receive an amount in cash equal to $24.00 for each Share underlying the RSUs (the aggregate amount, the \"RSU Payment\").  Subject to the terms of the award agreement, the RSU Payment will generally be payable (without any crediting of interest for the period from the consummation of the Offer through the date of payment) in three annual installments with each such installment paid on the date that the RSUs corresponding to such installment would have otherwise vested in accordance with the terms of the award, less any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6085},"source":{"system":"sec-edgar","filing":"0000884731-17-000048","document":"wf-form4_148727245801390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000048/wf-form4_148727245801390.xml","form_type":"4"}},{"id":4443817,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. V. P. - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2017-02-16T14:14:32.000Z","date":"2017-02-16","kind":"disposition_to_issuer","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a right to receive one Share. Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the Offer automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum cash payment in an amount equal to $24.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a right to receive one Share. Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the Offer automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum cash payment in an amount equal to $24.00 for each Share underlying the RSU, less any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000884731-17-000048","document":"wf-form4_148727245801390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000048/wf-form4_148727245801390.xml","form_type":"4"}},{"id":4443816,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. V. P. - General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-02-16T14:14:32.000Z","date":"2017-02-16","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."}],"balance_after":0,"derivative":{"exercise_price":7.13,"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000884731-17-000048","document":"wf-form4_148727245801390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000048/wf-form4_148727245801390.xml","form_type":"4"}},{"id":4465022,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":73227,"kind":"person","name":"Kogan Elona","position":1,"cik":"0001679971","reported_name":"Kogan Elona Esq.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. V. P. - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2017-02-07T16:59:07.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":6085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Units (\"RSUs\") vest as to approximately one-third of the shares underlying the RSUs on each anniversary of the grant date; provided, however, that, subject to and effective upon the consummation of the transactions contemplated by that certain Agreement and Plan of Merger between ARIAD, Takeda Pharmaceutical Company Limited, and Kiku Merger Co., Inc., dated January 8, 2017, the RSUs shall be converted into the right to receive a cash amount equal to $24.00 for each share of common stock underlying the RSUs, payable in three annual installments on each anniversary of the grant date, subject to the terms of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"N/A"}],"balance_after":6085,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6085},"source":{"system":"sec-edgar","filing":"0000884731-17-000031","document":"wf-form4_148650473314100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000031/wf-form4_148650473314100.xml","form_type":"4"}}]}